A Discussion on Japan’s Bioeconomy and Key Policy Considerations

3:00 PM - 3:45 PM (EDT), Wednesday, June 16, 2021
Search General Info
Search Education
Search Partnering Companies

As Japan pursues its bioeconomy strategy, there are a variety of key policy considerations that can help ensure best possible outcomes for patients and communities in Japan and globally and enable Japan to become a leader in the global life sciences sector. Join industry experts and thought leaders on this panel for a discussion on opportunities and challenges in Japan’s biotech sector. Panelists will share their views on key policies to promote biotech innovation in Japan from Japanese industry, multinationals, and venture capital communities.

Japan Representative
Pharmaceutical Research and Manufacturers of America (PhRMA)
President, Japan Bioindustry Association;
Senior Advisor and Honorary Chairman, Chugai Pharma
Founder and Managing Partner
Catalys Pacific
President and Representative Director
Amgen K.K.